{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:33:31Z","timestamp":1792506811284,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.placenta.2011.11.021","type":"journal-article","created":{"date-parts":[[2011,12,23]],"date-time":"2011-12-23T22:45:37Z","timestamp":1324680337000},"page":"S42-S47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":164,"special_numbering":"S","title":["Review: Biochemical markers to predict preeclampsia"],"prefix":"10.1016","volume":"33","author":[{"given":"U.D.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.G.","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.H.","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"\u00c5kerstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.R.","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9249","key":"10.1016\/j.placenta.2011.11.021_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(00)03577-7","article-title":"Pathogenesis and genetics of pre-eclampsia","volume":"357","author":"Roberts","year":"2001","journal-title":"Lancet"},{"issue":"25\u201326","key":"10.1016\/j.placenta.2011.11.021_bib2","doi-asserted-by":"crossref","first-page":"949","DOI":"10.5694\/j.1326-5377.1975.tb106465.x","article-title":"Gynaecology from ancient Egypt: The Papyrus Kahun: a translation of the oldest treatise on gynaecology that has survived from the ancient world","volume":"2","author":"Stevens","year":"1975","journal-title":"Med J Aust"},{"issue":"Suppl. A","key":"10.1016\/j.placenta.2011.11.021_bib3","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.placenta.2008.11.009","article-title":"The two stage model of preeclampsia: variations on the theme","volume":"30","author":"Roberts","year":"2009","journal-title":"Placenta"},{"issue":"5","key":"10.1016\/j.placenta.2011.11.021_bib4","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1067\/mob.2002.127305","article-title":"The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature","volume":"187","author":"Brosens","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"9181","key":"10.1016\/j.placenta.2011.11.021_bib5","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0140-6736(99)80002-6","article-title":"Is oxidative stress the link in the two-stage model of pre-eclampsia?","volume":"354","author":"Roberts","year":"1999","journal-title":"Lancet"},{"issue":"9267","key":"10.1016\/j.placenta.2011.11.021_bib6","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/S0140-6736(00)04694-8","article-title":"Prevention of pre-eclampsia","volume":"357","author":"Shennan","year":"2001","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.placenta.2011.11.021_bib7","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1161\/01.RES.0000024411.22110.AA","article-title":"Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia","volume":"90","author":"Hung","year":"2002","journal-title":"Circ Res"},{"issue":"520","key":"10.1016\/j.placenta.2011.11.021_bib8","first-page":"e1","article-title":"Fetal hemoglobin and alpha(1)-microglobulin as first- and early second-trimester predictive biomarkers for preeclampsia","volume":"204(6)","author":"Anderson","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.placenta.2011.11.021_bib9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.placenta.2011.01.017","article-title":"Perfusion of human placenta with hemoglobin introduces preeclampsia-like injuries that are prevented by alpha1-microglobulin","volume":"32","author":"May","year":"2011","journal-title":"Placenta"},{"issue":"3","key":"10.1016\/j.placenta.2011.11.021_bib10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bpobgyn.2010.10.016","article-title":"Oxidative stress","volume":"25","author":"Burton","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.placenta.2011.11.021_bib11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0735-6757(02)42241-3","article-title":"A\u00a0current concept of eclampsia","volume":"21","author":"Lipstein","year":"2003","journal-title":"Am J Emerg Med"},{"issue":"1","key":"10.1016\/j.placenta.2011.11.021_bib12","doi-asserted-by":"crossref","first-page":"IX","DOI":"10.3109\/10641950109152635","article-title":"The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)","volume":"20","author":"Brown","year":"2001","journal-title":"Hypertens Pregnancy"},{"issue":"2","key":"10.1016\/j.placenta.2011.11.021_bib13","first-page":"330","article-title":"ACOG practice bulletin on diagnosing and managing preeclampsia and eclampsia. American College of Obstetricians and Gynecologists","volume":"66","author":"Schroeder","year":"2002","journal-title":"Am Fam Physician"},{"issue":"5728","key":"10.1016\/j.placenta.2011.11.021_bib14","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1126\/science.1111726","article-title":"Latest advances in understanding preeclampsia","volume":"308","author":"Redman","year":"2005","journal-title":"Science"},{"issue":"7491","key":"10.1016\/j.placenta.2011.11.021_bib15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/bmj.38380.674340.E0","article-title":"Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies","volume":"330","author":"Duckitt","year":"2005","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.placenta.2011.11.021_bib16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/pd.2660","article-title":"Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks","volume":"31","author":"Akolekar","year":"2011","journal-title":"Prenat Diagn"},{"issue":"3","key":"10.1016\/j.placenta.2011.11.021_bib17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF02114602","article-title":"Serum PAPP-A in normal pregnancy: relationship to fetal and maternal characteristics","volume":"233","author":"Westergaard","year":"1983","journal-title":"Arch Gynecol"},{"issue":"9","key":"10.1016\/j.placenta.2011.11.021_bib18","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/humrep\/den224","article-title":"Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A","volume":"23","author":"Kagan","year":"2008","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.placenta.2011.11.021_bib19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejogrb.2011.03.004","article-title":"Decreased PAPP-A is associated with preeclampsia, premature delivery and small for gestational age infants but not with placental abruption","volume":"157","author":"Ranta","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"10.1016\/j.placenta.2011.11.021_bib20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.placenta.2011.01.016","article-title":"First-trimester serum analytes, biophysical tests and the association with pathological morphometry in the placenta of pregnancies with preeclampsia and fetal growth restriction","volume":"32","author":"Odibo","year":"2011","journal-title":"Placenta"},{"issue":"10","key":"10.1016\/j.placenta.2011.11.021_bib21","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/pd.1251","article-title":"Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler","volume":"25","author":"Spencer","year":"2005","journal-title":"Prenat Diagn"},{"issue":"4","key":"10.1016\/j.placenta.2011.11.021_bib22","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1210\/jcem.87.4.8430","article-title":"Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth","volume":"87","author":"Smith","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12\u201313","key":"10.1016\/j.placenta.2011.11.021_bib23","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/pd.2627","article-title":"Predicting the risk of pre-eclampsia between 11 and 13 weeks\u2019 gestation by combining maternal characteristics and serum analytes, PAPP-A and free beta-hCG","volume":"30","author":"Goetzinger","year":"2010","journal-title":"Prenat Diagn"},{"issue":"1","key":"10.1016\/j.placenta.2011.11.021_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/uog.6280","article-title":"First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia","volume":"33","author":"Poon","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.placenta.2011.11.021_bib25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/pd.1890","article-title":"Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia","volume":"28","author":"Spencer","year":"2008","journal-title":"Prenat Diagn"},{"issue":"7","key":"10.1016\/j.placenta.2011.11.021_bib26","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3109\/14767058.2010.531320","article-title":"Late pregnancy associated plasma protein A levels decrease in preterm labor","volume":"24","author":"Atis","year":"2011","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"5","key":"10.1016\/j.placenta.2011.11.021_bib27","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.fertnstert.2007.09.030","article-title":"Placental expression profiling in preeclampsia: local overproduction of hemoglobin may drive pathological changes","volume":"90","author":"Centlow","year":"2008","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.placenta.2011.11.021_bib28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.abb.2005.02.006","article-title":"Vascular damage by unstable hemoglobins: the role of heme-depleted globin","volume":"436","author":"Tsemakhovich","year":"2005","journal-title":"Arch Biochem Biophys"},{"issue":"4","key":"10.1016\/j.placenta.2011.11.021_bib29","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/01.ATV.0000204350.44226.9a","article-title":"Unraveling the reactions of nitric oxide, nitrite, and hemoglobin in physiology and therapeutics","volume":"26","author":"Kim-Shapiro","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.placenta.2011.11.021_bib30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.toxlet.2005.03.004","article-title":"Free heme toxicity and its detoxification systems in human","volume":"157","author":"Kumar","year":"2005","journal-title":"Toxicol Lett"},{"issue":"6","key":"10.1016\/j.placenta.2011.11.021_bib31","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1182\/blood.V99.6.1894","article-title":"Processing of the lipocalin alpha(1)-microglobulin by hemoglobin induces heme-binding and heme-degradation properties","volume":"99","author":"Allhorn","year":"2002","journal-title":"Blood"},{"issue":"43","key":"10.1016\/j.placenta.2011.11.021_bib32","doi-asserted-by":"crossref","first-page":"31493","DOI":"10.1074\/jbc.M702624200","article-title":"The lipocalin alpha1-microglobulin has radical scavenging activity","volume":"282","author":"Akerstrom","year":"2007","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.placenta.2011.11.021_bib33","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.freeradbiomed.2009.10.052","article-title":"Increased levels of cell-free hemoglobin, oxidation markers, and the antioxidative heme scavenger alpha(1)-microglobulin in preeclampsia","volume":"48","author":"Olsson","year":"2010","journal-title":"Free Radic Biol Med"},{"issue":"8","key":"10.1016\/j.placenta.2011.11.021_bib34","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1080\/10715760802337265","article-title":"The lipocalin alpha1-microglobulin protects erythroid K562 cells against oxidative damage induced by heme and reactive oxygen species","volume":"42","author":"Olsson","year":"2008","journal-title":"Free Radic Res"},{"issue":"6","key":"10.1016\/j.placenta.2011.11.021_bib35","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.freeradbiomed.2006.12.017","article-title":"Up-regulation of alpha1-microglobulin by hemoglobin and reactive oxygen species in hepatoma and\u00a0blood cell lines","volume":"42","author":"Olsson","year":"2007","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"10.1016\/j.placenta.2011.11.021_bib36","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1432-1033.2004.04004.x","article-title":"Functional analyses of placental protein 13\/galectin-13","volume":"271","author":"Than","year":"2004","journal-title":"Eur J Biochem"},{"issue":"11","key":"10.1016\/j.placenta.2011.11.021_bib37","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/protein\/14.11.875","article-title":"Homology modelling and molecular dynamics studies of human placental tissue protein 13 (galectin-13)","volume":"14","author":"Visegrady","year":"2001","journal-title":"Protein Eng"},{"issue":"12","key":"10.1016\/j.placenta.2011.11.021_bib38","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/pd.2375","article-title":"Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia","volume":"29","author":"Akolekar","year":"2009","journal-title":"Prenat Diagn"},{"issue":"6","key":"10.1016\/j.placenta.2011.11.021_bib39","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/uog.7559","article-title":"First-trimester markers for the prediction of pre-eclampsia in women with a-priori high risk","volume":"35","author":"Khalil","year":"2010","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.placenta.2011.11.021_bib40","doi-asserted-by":"crossref","first-page":"122e1","DOI":"10.1016\/j.ajog.2008.01.013","article-title":"First-trimester maternal serum PP13 in the risk assessment for preeclampsia","volume":"199","author":"Romero","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.placenta.2011.11.021_bib41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/uog.2686","article-title":"A\u00a0novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound","volume":"27","author":"Nicolaides","year":"2006","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.placenta.2011.11.021_bib42","article-title":"Placental Protein-13 and pregnancy-associated plasma Protein-A as first trimester screening markers for hypertensive disorders and small for gestational age outcomes","author":"Stamatopoulou","year":"2010","journal-title":"Hypertens Pregnancy"},{"issue":"7","key":"10.1016\/j.placenta.2011.11.021_bib43","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.placenta.2011.11.021_bib44","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.placenta.2011.11.021_bib45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev.med.59.110106.214058","article-title":"Preeclampsia and angiogenic imbalance","volume":"59","author":"Maynard","year":"2008","journal-title":"Annu Rev Med"},{"issue":"2","key":"10.1016\/j.placenta.2011.11.021_bib46","doi-asserted-by":"crossref","first-page":"e4453","DOI":"10.1371\/journal.pone.0004453","article-title":"Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia","volume":"4","author":"Reddy","year":"2009","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.placenta.2011.11.021_bib47","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"10.1016\/j.placenta.2011.11.021_bib48","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1097\/01.AOG.0000264552.85436.a1","article-title":"Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia","volume":"109","author":"Wikstrom","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.placenta.2011.11.021_bib49","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/HYPERTENSIONAHA.107.092098","article-title":"Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia","volume":"50","author":"Li","year":"2007","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.placenta.2011.11.021_bib50","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/14767050802034545","article-title":"The\u00a0change in concentrations of angiogenic and anti-angiogenic factors in\u00a0maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age","volume":"21","author":"Erez","year":"2008","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"6","key":"10.1016\/j.placenta.2011.11.021_bib51","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/uog.7621","article-title":"Maternal plasma soluble endoglin at 11-13 weeks\u2019 gestation in pre-eclampsia","volume":"35","author":"Foidart","year":"2010","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.placenta.2011.11.021_bib52","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/pd.2433","article-title":"Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia","volume":"30","author":"Akolekar","year":"2010","journal-title":"Prenat Diagn"},{"issue":"2","key":"10.1016\/j.placenta.2011.11.021_bib53","doi-asserted-by":"crossref","first-page":"161e1","DOI":"10.1016\/j.ajog.2009.09.016","article-title":"An automated method for the determination of the sFlt-1\/PIGF ratio in the assessment of preeclampsia","volume":"202","author":"Verlohren","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.placenta.2011.11.021_bib54","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/00016340802253759","article-title":"Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia","volume":"87","author":"De Vivo","year":"2008","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"10.1016\/j.placenta.2011.11.021_bib55","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1161\/HYPERTENSIONAHA.110.157297","article-title":"Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers","volume":"56","author":"Kenny","year":"2010","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.placenta.2011.11.021_bib56","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1080\/00016340701318133","article-title":"Cystatin C, beta-2-microglobulin and beta-trace protein in pre-eclampsia","volume":"86","author":"Kristensen","year":"2007","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"7","key":"10.1016\/j.placenta.2011.11.021_bib57","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/003655101753218346","article-title":"Serum cystatin C is a better marker for preeclampsia than serum creatinine or serum urate","volume":"61","author":"Strevens","year":"2001","journal-title":"Scand J Clin Lab Invest"},{"issue":"6","key":"10.1016\/j.placenta.2011.11.021_bib58","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1080\/00365510701203488","article-title":"Temporal changes of the plasma levels of cystatin C, beta-trace protein, beta2-microglobulin, urate and creatinine during pregnancy indicate continuous alterations in the renal filtration process","volume":"67","author":"Kristensen","year":"2007","journal-title":"Scand J Clin Lab Invest"},{"issue":"8","key":"10.1016\/j.placenta.2011.11.021_bib59","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1177\/1933719109336618","article-title":"Raised maternal serum cystatin C: an early pregnancy marker for preeclampsia","volume":"16","author":"Thilaganathan","year":"2009","journal-title":"Reprod Sci"},{"issue":"6","key":"10.1016\/j.placenta.2011.11.021_bib60","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/AOG.0b013e3181dd5137","article-title":"Early-pregnancy multiple serum markers and second-trimester uterine artery Doppler in predicting preeclampsia","volume":"115","author":"Thilaganathan","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.placenta.2011.11.021_bib61","doi-asserted-by":"crossref","first-page":"575e1","DOI":"10.1016\/j.ajog.2010.07.043","article-title":"Performance of messenger RNAs circulating in maternal blood in the prediction of preeclampsia at 10-14 weeks","volume":"203","author":"Farina","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.placenta.2011.11.021_bib62","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/bdra.20782","article-title":"Expression patterns of placental microRNAs","volume":"91","author":"Mouillet","year":"2011","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"11","key":"10.1016\/j.placenta.2011.11.021_bib63","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1471-0528.2010.02690.x","article-title":"First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia","volume":"117","author":"Wortelboer","year":"2010","journal-title":"BJOG"},{"issue":"383","key":"10.1016\/j.placenta.2011.11.021_bib64","first-page":"e1","article-title":"Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women","volume":"203(4)","author":"Audibert","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.placenta.2011.11.021_bib65","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.placenta.2011.05.006","article-title":"First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia","volume":"32","author":"Odibo","year":"2011","journal-title":"Placenta"},{"issue":"4","key":"10.1016\/j.placenta.2011.11.021_bib66","first-page":"728","article-title":"Financial impact of a novel pre-eclampsia diagnostic test versus standard practice: a decision-analytic modeling analysis from a UK healthcare payer perspective","volume":"13","author":"Hadker","year":"2010","journal-title":"J\u00a0Med Econ"},{"issue":"Suppl","key":"10.1016\/j.placenta.2011.11.021_bib67","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.placenta.2010.07.015","article-title":"Screening for pre-eclampsia\u2013lessons from aneuploidy screening","volume":"32","author":"Cuckle","year":"2011","journal-title":"Placenta"}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400411005534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400411005534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:45:19Z","timestamp":1758908719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400411005534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":67,"alternative-id":["S0143400411005534"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2011.11.021","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review: Biochemical markers to predict preeclampsia","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2011.11.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}